Gene Therapy services

 

Category: *CDMO

Exhibitor: FUJIFILM CORPORATION

Booth No: M208

 

Characteristic

 

Across our global network, multiple entry points offer maximum flexibility to efficiently serve our partners’ needs
Whether you choose full process development or enter the network through multi-candidate screening and feasibility assessment, we partner with you to bring late-phase manufacturing concepts to early-phase process design.
Our approach is to create simple, streamlined, modular paths that minimize risk and improve affordability, while platform analytics and processes minimize process development time. We also offer a more tailored approach in cases where an improvement in product quality or titer is required.

Being your viral gene therapy CDMO partner means we work with you to structure programs with the end goal of regulatory submissions in sight. Therefore, CMC considerations are built into the fabric of the work. With extensive experience in both suspension and adherent production for gene therapies (AAV, AdV, LV, HSV and Retrovirus), oncolytic viruses (AAV, AdV and HSV) and viral vaccines, we implement the scalable and robust processes to meet your future market demands.

 

Other Products

 

• 

  Fujifilm’s nanotechnology enhances your compound's possibilities with liposomes.

• 

  mRNA formulation with lipid nanoparticles(LNPs)

• 

  Cell Therapy services

• 

  Mammalian Cell Culture CDMO services

 

 

 

Back